Lawyers for the Lifecycle of Foods, Dietary Supplements, Cosmetics, Drugs & Medical Devices
Meet the Modernization of Cosmetics Regulation Act of 2022
Once signed into law, the Modernization of Cosmetics Regulations Act of 2022 (MOCRA) will add significant new authorities to chapter VI of the Federal Food, Drug, and Cosmetic Act (FDCA).
see all news >Food, Beverage, Dietary Supplement & Cosmetic Compliance
We support clients throughout the entire lifecycle of products aimed at improving the population's health and wellness.
MOREIntellectual Property Protection
Drawing heavily on our IP, patent, trade secret, and trademark expertise, we provide our clients with business advice and strategies that enhance product value and prevent future litigation.
MORETrial Practice, Litigation & Dispute Resolution
We have a strong track record in disputes related to FDA, FTC, Proposition 65, consumer false advertising class actions, patent & trademark infringement, supply chain, technology, software, e-commerce and breach of contract claims.
MOREMedical Device & Drug Compliance
We provide strategic advice to clients from the inception of their drug and device products with a focus on enhancing product value, gaining regulatory approvals, and ensuring compliance.
MORE-
news
Ivan Wasserman Quoted in “Phishing Attack Styled as Demand Letters Targets Natural Products Industry”
Hank Schultz, Senior Editor, Natural Products Insider, turned to Ivan Wasserman for comment on phony-looking letters being sent to the natural products industry demanding cash to forestall the filing of a lawsuit that have come from an apparently fictitious law firm Ivan stated that “a little bit of sleuthing helped us to quickly identify these […]
-
news
MoCRA Update: FDA Responds to Public Comments Regarding the Registration and Listing of Cosmetic Product Facilities and Products — Guidance for Industry
In response to FDA’s August 2023 draft Registration and Listing of Cosmetic Product Facilities and Products: Guidance for Industry (“draft guidance”), FDA received 49 public comments by the Sept. 5, 2023, deadline. The comments included requests to update the accuracy of FDA’s burden estimates; suggestions regarding ways to enhance the quality, utility, and clarity of the information to be collected; suggestions […]
-
news
Matthew Orr Quoted in “Walmart’s Motion to Dismiss Denied: Fish Oil Suit Remains on the Docket”
Matthew Orr spoke with NutraIngredients-USA about the status of a class action lawsuit in which plaintiff alleges that a Walmart fish oil supplement is mischaracterized as fish oil and instead made from fish waste.
